SCHEMBL2875968

SCHEMBL2875968

CC1CC2C3CCC4=CC(=O)C=C(O)C4(C)C3CCC2(C)C1(O)C(=O)CO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 6/20 0.55
NFKB1 P19838 4/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
KCNH2 Q12809 1/20 0.49
HSD17B10 Q99714 8/20 0.48
CYP3A4 P08684 7/20 0.48
HIF1A Q16665 6/20 0.48
PGR P06401 5/20 0.48
AR P10275 4/20 0.48
TSHR P16473 3/20 0.48
LMNA P02545 3/20 0.48
PMP22 Q01453 2/20 0.48
BLM P54132 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ABCB11 O95342 2/20 0.48
NR3C2 P08235 2/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3640143 1.00 NR3C1 (0.55) NR3C1NFKB1NFKB2RELAKCNH2
SCHEMBL30600014 0.90 SERPINA6 (0.52) NR3C1NFKB1HSD17B10CYP3A4HIF1A
SCHEMBL3720190 0.90 SERPINA6 (0.52) NR3C1NFKB1HSD17B10CYP3A4HIF1A
SCHEMBL4557526 0.90 SERPINA6 (0.52) NR3C1NFKB1HSD17B10CYP3A4HIF1A
SCHEMBL4557524 0.90 SERPINA6 (0.52) NR3C1NFKB1HSD17B10CYP3A4HIF1A
SCHEMBL4556901 0.89 HSD17B10 (0.45) NR3C1NFKB1NFKB2RELAKCNH2
SCHEMBL7945795 0.87 HSD17B10 (0.43) NR3C1NFKB1NFKB2RELAKCNH2
SCHEMBL5459012 0.84 HSD17B10 (0.64) NR3C1NFKB1HSD17B10CYP3A4HIF1A
SCHEMBL3726244 0.84 HSD17B10 (0.64) NR3C1NFKB1HSD17B10CYP3A4HIF1A
SCHEMBL11267812 0.83 NR3C1 (0.72) NR3C1NFKB1NFKB2RELAKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3350313-A1 DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS Agency For Science, Technology And Research (A*star) (SG) 2018-07-25 EP claimed
WO-2017048193-A1 DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) 2017-03-23 WO claimed
WO-2025137391-A1 BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 4 VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed
EP-3873580-A1 IMPLANTATION NEEDLE AND KIT F. Hoffmann-La Roche AG (CH) 2021-09-08 EP disclosed
EP-3350313-A1 DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS Agency For Science, Technology And Research (A*star) (SG) 2018-07-25 EP disclosed
WO-2017048193-A1 DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) 2017-03-23 WO disclosed
EP-2914112-A1 TREATMENT OF CANCER WITH POMALIDOMIDE IN A RENALLY IMPAIRED SUBJECT Celgene Corporation (US) 2015-09-09 EP disclosed
WO-2015105981-A2 CONDITIONAL ESSENTIALITY OF HMB ABBOTT LABORATORIES (US) 2015-07-16 WO disclosed
WO-2014071280-A1 TREATMENT OF CANCER WITH POMALIDOMIDE IN A RENALLY IMPAIRED SUBJECT CELGENE CORPORATION (US) 2014-05-08 WO disclosed
EP-2637665-A1 DEXAMETHASONE COMBINATION THERAPY Board Of Regents, The University Of Texas System (US) 2013-09-18 EP disclosed
WO-2012065021-A1 DEXAMETHASONE COMBINATION THERAPY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-05-18 WO disclosed
WO-2010102120-A2 METHODS AND COMPOSITIONS TO DIAGNOSE PAIN WARSAW ORTHOPEDIC, INC. (US) 2010-09-10 WO disclosed